NASDAQ:TPST

Tempest Therapeutics Stock Predictions

etoro logo Buy TPST
*Your capital is at risk
$1.27
-0.0400 (-3.05%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TPST Prediction Chart

TPST Predictions History

Latest community submissions for TPST.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 11, 2025 $8.57 -3.51% $7.47 V 85.30% 1
Jun 11, 2025 $8.68 -2.20% $7.47 V 83.74% 1
Jun 11, 2025 Bullish $7.47 X 0
Mar 6, 2025 Bullish $0.83 X 1
Oct 17, 2024 $1.04 -92.77% $1.15 V 90.78% 0
Oct 17, 2024 $1.15 -92.02% $1.15 X 99.89% 6
Oct 17, 2024 Bullish $1.15 X 1
Oct 17, 2024 Bullish $1.15 X 1
Jul 3, 2024 Bullish $2.11 X 0
JS JS Pro
Jun 18, 2024 $3.00 +3.09% $2.85 X 94.74% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TPST with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TEMPEST THERAPEUTICS INC.
Tempest Therapeutics
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops T...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE